Canaccord Genuity Starts Evolent Health (EVH) at Buy

Canaccord Genuity initiates coverage on Evolent Health (NYSE: EVH) with a Buy rating and a price target of $21.00.

Analyst Richard Close commented, "Evolent is a leading consulting and technology-enabled solution provider for health systems assuming "risk" and transitioning to value-based care. The company provides managerial and operational expertise, enabling health system clients to remain competitive in the changing environment. Considering the accelerating trend towards "value," we expect Evolent to experience ~30% top-line growth from current clients expanding value-based care efforts, complemented by new client wins. While the company is still young, the business model is attractive with sticky, long-term contracts and 80%+ revenue visibility. We believe Evolent provides the best exposure for investors to play the accelerating trend towards provider adoption of value-based care initiatives."

For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.

Shares of Evolent Health closed at $12.03 yesterday.

You May Also Be Interested In

• BMO Capital Starts Amapa Minerals Holdings (AMAP:CN) at Outperform
• Nomura/Instinet Starts Unitree Robotics (688836:CH) at Buy
• Freedom Capital Starts Hut 8 Mining Corp. (HUT) at Buy